Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Toxoplasmosis Overview 6 Therapeutics Development 7 Pipeline Products for Toxoplasmosis - Overview 7 Pipeline Products for Toxoplasmosis - Comparative Analysis 8 Toxoplasmosis - Therapeutics under Development by Companies 9 Toxoplasmosis - Therapeutics under Investigation by Universities/Institutes 10 Toxoplasmosis - Pipeline Products Glance 11 Early Stage Products 11 Toxoplasmosis - Products under Development by Companies 12 Toxoplasmosis - Products under Investigation by Universities/Institutes 13 Toxoplasmosis - Companies Involved in Therapeutics Development 14 Turing Pharmaceuticals AG 14 Toxoplasmosis - Therapeutics Assessment 15 Assessment by Monotherapy Products 15 Assessment by Target 16 Assessment by Mechanism of Action 18 Assessment by Molecule Type 20 Drug Profiles 22 Monoclonal Antibody for Toxoplasmosis - Drug Profile 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Polysaccharide for Oncology, Infectious Disease and Allergy - Drug Profile 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecule to Inhibit Histone Deacetylase for Toxoplasmosis and Other Parasitic Diseases - Drug Profile 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecules for Toxoplasmosis - Drug Profile 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 toxoplasmosis vaccine - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 toxoplasmosis vaccine - Drug Profile 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 toxoplasmosis vaccine - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 TRP-004 - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Toxoplasmosis - Dormant Projects 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 31 Disclaimer 32

Turing Pharmaceuticals AG